ClearBridge Investments’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
ClearBridge Investments's BLUE Position: Q3 2020 in Review
ClearBridge Investments sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 28 shares — an estimated $22K sold.
ClearBridge Investments first reported a position in BLUE in Q3 2013 and held it in 28 quarters. The position peaked at $157K in Q4 2017. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.
- ClearBridge Investments reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
- ClearBridge Investments sold 28 bluebird bio shares in Q3 2020, an estimated $22K.
- ClearBridge Investments first reported a position in bluebird bio in Q3 2013 and held it in 28 quarters.
- ClearBridge Investments's bluebird bio position peaked at $157K in Q4 2017.
- 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.
Based on ClearBridge Investments's 13F filing for Q3 2020, filed 12 Nov 2020.